[Medication for ADHD and the risk of cardiovascular mortality].
Kalverdijk
L J
LJ
Buitelaar
J K
JK
van der Gaag
R J
RJ
D000661:Amphetamine / Q000009:adverse effects / Q000627:therapeutic use; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy*; D000697:Central Nervous System Stimulants / Q000009:adverse effects* / Q000627:therapeutic use; D016757:Death, Sudden, Cardiac / Q000209:etiology*; D006801:Humans; D017410:Practice Guidelines as Topic
D000697:Central Nervous System Stimulants; D000661:Amphetamine